Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian C Callaghan

Showing results (101-110 of 163) with videos related to

Pageof 17
Sort By:
JAMA Neurology|March 3, 2025
Diagnostic Testing for Patients With Peripheral NeuropathyBrian C Callaghan, Evan L Reynolds, Lavanya Muthukumar, et al.
Neurology|July 19, 2020
The effects of the Medicare NCS reimbursement policy: Utilization, payments, and patient accessEvan L Reynolds, Kevin A Kerber, Chloe Hill, et al.
Neurology|May 3, 2019
Out-of-pocket costs are on the rise for commonly prescribed neurologic medicationsBrian C Callaghan, Evan Reynolds, Mousumi Banerjee, et al.
Journal of Evaluation in Clinical Practice|August 6, 2020
Primary care providers perform more neurologic visits than neurologists among Medicare beneficiariesChun Chieh Lin, Chloe E Hill, James F Burke, et al.
JCI Insight|February 8, 2023
The determinants of complication trajectories in American Indians with type 2 diabetesEvan L Reynolds, Gulcin Akinci, Mousumi Banerjee, et al.
Neurology|July 25, 2012
A prescription for the Epley maneuver: www.youtube.com?Kevin A Kerber, James F Burke, Lesli E Skolarus, et al.
JAMA Neurology|July 23, 2014
Role of neurologists and diagnostic tests on the management of distal symmetric polyneuropathyBrian C Callaghan, Kevin A Kerber, Lynda L Lisabeth, et al.
Annals of Internal Medicine|January 6, 2026
Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists on Diabetic Foot Disease : An Emulated Target TrialFrederik P B Kristensen, Diana H Christensen, Brian C Callaghan, et al.
Neurology|October 28, 2018
Unintended consequences of Mayo paraneoplastic evaluationsMatthew J Ebright, Shih-Hon Li, Evan Reynolds, et al.
Annals of Clinical and Translational Neurology|April 25, 2018
Diabetes and obesity are the main metabolic drivers of peripheral neuropathyBrian C Callaghan, LeiLi Gao, Yufeng Li, et al.
Pageof 17

Showing results (101-110 of 163) with videos related to

Sort By:
Pageof 17
JAMA Neurology|March 3, 2025
Diagnostic Testing for Patients With Peripheral NeuropathyBrian C Callaghan, Evan L Reynolds, Lavanya Muthukumar, et al.
Neurology|July 19, 2020
The effects of the Medicare NCS reimbursement policy: Utilization, payments, and patient accessEvan L Reynolds, Kevin A Kerber, Chloe Hill, et al.
Neurology|May 3, 2019
Out-of-pocket costs are on the rise for commonly prescribed neurologic medicationsBrian C Callaghan, Evan Reynolds, Mousumi Banerjee, et al.
Journal of Evaluation in Clinical Practice|August 6, 2020
Primary care providers perform more neurologic visits than neurologists among Medicare beneficiariesChun Chieh Lin, Chloe E Hill, James F Burke, et al.
JCI Insight|February 8, 2023
The determinants of complication trajectories in American Indians with type 2 diabetesEvan L Reynolds, Gulcin Akinci, Mousumi Banerjee, et al.
Neurology|July 25, 2012
A prescription for the Epley maneuver: www.youtube.com?Kevin A Kerber, James F Burke, Lesli E Skolarus, et al.
JAMA Neurology|July 23, 2014
Role of neurologists and diagnostic tests on the management of distal symmetric polyneuropathyBrian C Callaghan, Kevin A Kerber, Lynda L Lisabeth, et al.
Annals of Internal Medicine|January 6, 2026
Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists on Diabetic Foot Disease : An Emulated Target TrialFrederik P B Kristensen, Diana H Christensen, Brian C Callaghan, et al.
Neurology|October 28, 2018
Unintended consequences of Mayo paraneoplastic evaluationsMatthew J Ebright, Shih-Hon Li, Evan Reynolds, et al.
Annals of Clinical and Translational Neurology|April 25, 2018
Diabetes and obesity are the main metabolic drivers of peripheral neuropathyBrian C Callaghan, LeiLi Gao, Yufeng Li, et al.
Pageof 17